Sterically Stabilized Liposomes Incorporating the Novel Anticancer Agent Phospho-Ibuprofen (MDC-917): Preparation, Characterization, and In Vitro/In Vivo Evaluation

被引:0
|
作者
George Mattheolabakis
Ting Nie
Panayiotis P. Constantinides
Basil Rigas
机构
[1] Stony Brook University Stony Brook,Division of Cancer Prevention, Department of Medicine
[2] Medicon Pharmaceuticals,undefined
[3] Inc.,undefined
来源
Pharmaceutical Research | 2012年 / 29卷
关键词
anticancer agent; liposomes; NSAIDs; pegylated phospholipids; phospho-ibuprofen;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1435 / 1443
页数:8
相关论文
共 4 条
  • [1] Sterically Stabilized Liposomes Incorporating the Novel Anticancer Agent Phospho-Ibuprofen (MDC-917): Preparation, Characterization, and In Vitro/In Vivo Evaluation
    Mattheolabakis, George
    Nie, Ting
    Constantinides, Panayiotis P.
    Rigas, Basil
    PHARMACEUTICAL RESEARCH, 2012, 29 (06) : 1435 - 1443
  • [2] Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo
    Nie, T.
    Wong, C. C.
    Alston, N.
    Aro, P.
    Constantinides, P. P.
    Rigas, B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (03) : 991 - 1001
  • [3] Phospho-Ibuprofen (MDC-917) Is a Novel Agent against Colon Cancer: Efficacy, Metabolism, and Pharmacokinetics in Mouse Models
    Xie, Gang
    Sun, Yu
    Nie, Ting
    Mackenzie, Gerardo G.
    Huang, Liqun
    Kopelovich, Levy
    Komninou, Despina
    Rigas, Basil
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (03): : 876 - 886
  • [4] Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent
    Parise, Amelia
    Milelli, Andrea
    Tumiatti, Vincenzo
    Minarini, Anna
    Neviani, Paolo
    Zuccari, Guendalina
    DRUG DELIVERY, 2015, 22 (05) : 590 - 597